Displaying drugs 10801 - 10825 of 12647 in total
Satavaptan
Satavaptan is under investigation in clinical trial NCT00359437 (Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver).
Investigational
Matched Description: … Recurrence in Patients With Ascites Due to Cirrhosis of the Liver). ... Satavaptan is under investigation in clinical trial NCT00359437 (Satavaptan in the Prevention of Ascites …
MK-1064
MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)).
Investigational
Matched Description: … and Pharmacodynamics of MK-1064 (MK-1064-001)). ... MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics …
Eltanexor
Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications).
Investigational
Matched Description: … Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications). ... Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and …
EDI-200
EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1.
Investigational
Matched Description: … human receptor binding domain of ectodysplasin-A1. ... EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the …
Tegileridine
Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain).
Investigational
Matched Description: … Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain). ... Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety of …
Aprinocarsen
Aprinocarsen is a specific antisense oligonucleotide inhibitor of protein kinase C-alpha.
Investigational
Matched Description: … Aprinocarsen is a specific antisense oligonucleotide inhibitor of protein kinase C-alpha. …
Lampalizumab
Lampalizumab has been used in trials studying the treatment of Geographic Atrophy.
Investigational
Matched Description: … Lampalizumab has been used in trials studying the treatment of Geographic Atrophy. …
Crenezumab
Crenezumab has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Crenezumab has been used in trials studying the treatment of Alzheimer's Disease. …
Placulumab
Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
Epicatechin
Epicatechin has been used in trials studying the treatment of Pre-diabetes.
Investigational
Matched Description: … Epicatechin has been used in trials studying the treatment of Pre-diabetes. …
Albaconazole
Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational
Matched Description: … Albaconazole has been used in trials studying the basic science of Onychomycosis. …
Vanillyl alcohol
Vanillyl alcohol has been used in trials studying the treatment of Smoking.
Investigational
Matched Description: … Vanillyl alcohol has been used in trials studying the treatment of Smoking. …
MBX-2982
MBX-2982 has been used in trials studying the treatment of Diabetes.
Investigational
Matched Description: … MBX-2982 has been used in trials studying the treatment of Diabetes. …
Vatelizumab
Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis.
Investigational
Matched Description: … Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis. …
CG-400549
CG400549 has been used in trials studying the treatment of Skin Infection.
Investigational
Matched Description: … CG400549 has been used in trials studying the treatment of Skin Infection. …
Lisofylline
Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.
Investigational
Matched Description: … Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus. …
GSK-1292263
GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Investigational
Matched Description: … GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2. …
Intepirdine
Intepirdine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Intepirdine has been used in trials studying the treatment of Alzheimer's Disease. …
Balugrastim
Balugrastim has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … Balugrastim has been used in trials studying the treatment of Solid Tumors. …
Solamargine
Solamargine has been used in trials studying the treatment of Actinic Keratosis.
Investigational
Matched Description: … Solamargine has been used in trials studying the treatment of Actinic Keratosis. …
Apricitabine
Apricitabine has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Apricitabine has been used in trials studying the treatment of HIV Infections. …
Disitertide
Disitertide has been used in trials studying the treatment of Skin Fibrosis.
Investigational
Matched Description: … Disitertide has been used in trials studying the treatment of Skin Fibrosis. …
Tregalizumab
Tregalizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Tregalizumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
KT-333
KT-333 is a small molecule targeted protein degrader of STAT3.
Investigational
Matched Description: … KT-333 is a small molecule targeted protein degrader of STAT3.[L44086] …
rAAV9-hNAGLU
rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase.
Investigational
Matched Description: … rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase. …
Displaying drugs 10801 - 10825 of 12647 in total